Medical devices, healthcare technology and the business of care
510(k) clearance · K260544

FMD Peripheral Guide Wire F-14 Flex 6; FMD Peripheral Guide Wire F-14 Tapered 40; FMD Peripheral Guide Wire F-18 Flex SP; FMD Peripheral Guide Wire F-18 DP 25; FMD Peripheral Guide Wire F-18 Tapered 40

FMD Co., Ltd. · Decision date Mar 20, 2026

FDA DECISIONK260544

What did the FDA decide?

FDA records K260544 as a 510(k) premarket notification, with a decision dated Mar 20, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Mar 20, 2026

FDA source record

Regulatory record facts

Identifier
K260544
Regulatory pathway
510(k) premarket notification
Applicant
FMD Co., Ltd.
Product code
DQX
Decision code
SESE
Decision date
Mar 20, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wire, Guide, Catheter.

Applicant
FMD Co., Ltd.
Product code
DQX
FDA device class
2

FDA decision timeline

  1. K260544 received

    Application receipt date recorded by FDA.

  2. K260544 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DQX

Product / regulatory recordCompanyPathwayDecision dateSource
Skycade Med Corporation510(k) clearanceOct 16, 2026FDA
Rapid-Medical , Ltd.510(k) clearanceSep 18, 2026FDA
Filmecc Co., Ltd.510(k) clearanceSep 3, 2026FDA
Sp Medical A/S510(k) clearanceJul 14, 2026FDA
Merit Medical Ireland , Ltd.510(k) clearanceJul 13, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

FMD Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shibuya-Ku

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records